Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine-Reference-Cited by-同舟云学术

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

Published:2007-04-21 Issue:5 Volume:26 Page:303-310
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Aristegui J.,Bernaola E.,Pocheville I.,García C.,Arranz L.,Durán G.,Pérez L.,Bastida M.,Canduela C.,Herranz Aguirre M.,Garrote E.,Fletcher M. A.,Pérez C.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-007-0294-4.pdf

Reference22 articles.

1. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin, L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187–195

2. Lin PL, Michaels MG, Janosky J, Ortenzo M, Wald ER, Mason EO Jr (2003) Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine. Pediatrics 111(4 Pt 1):896–899

3. Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B (2004) Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 23:485–489

4. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR (2004) Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 39:641–648

5. Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ (2004) Decrease of invasive pneumococcal infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113(3 Pt 1):443–449

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018;Frontiers in Pediatrics;2021-10-07

2. A historical perspective of MDR invasive pneumococcal disease in Spanish adults;Journal of Antimicrobial Chemotherapy;2020-11-30

3. Paediatric invasive pneumococcal disease on the island of Gran Canaria: 16-year prospective study (2001–2016);Enfermedades Infecciosas y Microbiología Clínica;2018-12

4. Paediatric invasive pneumococcal disease on the island of Gran Canaria: 16-year prospective study (2001–2016);Enfermedades infecciosas y microbiologia clinica (English ed.);2018-12

5. Pneumococcal Vaccination and Pneumonia Associated With Pleural Effusion in a Pediatric Population;Pediatric Infectious Disease Journal;2018-04